Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 26.49

+2.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: alruss who wrote (542)	7/15/1998 12:28:00 PM
From: Anthony Wong	Read Replies (1) of 1722

Johnson & Johnson Raised to Near-Term 'Buy' at Merrill and Zuercher Kantonalbank, Reiterated 'Hold' at BCV Bloomberg News July 15, 1998, 5:23 a.m. PT Princeton, New Jersey, July 15 (Bloomberg Data) -- Johnson & Johnson (JNJ US) was raised to near-term ''buy'' from near-term ''accumulate'' by analyst Vivian Wohl at Merrill Lynch & Co. The 12-month target price is $90.00 per share. The long-term rating remained ''b uy.'' -- Michael Donohue in Princeton, New Jersey, (609)279-3156 Bloomberg News July 15, 1998, 12:59 a.m. PT Zurich, July 15 (Bloomberg Data) -- Johnson & Johnson (JNJ US) was reiterated ''buy'' by analyst Giusep Demont at Zuercher Kantonalbank. Demont expects an EPS of $2.75 for 1998, and $3.12 for 1999, from $2.47 in 1997. Johnson & Johnson Reiterated 'Hold' at BCV Bloomberg News July 15, 1998, 6:21 a.m. PT Zurich, July 15 (Bloomberg Data) -- Johnson & Johnson (JNJ US) was reiterated ''hold'' by analyst Michael Strauss at Banque Cantonale Vaudoise. -- Olivier Thommen in Zurich, (41-1) 224 4116

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next